{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:03:00Z","timestamp":1790110980791,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","award":["T35DT9724"],"award-info":[{"award-number":["T35DT9724"]}],"id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K12 GM068524"],"award-info":[{"award-number":["K12 GM068524"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM007752"],"award-info":[{"award-number":["T32 GM007752"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM127121"],"award-info":[{"award-number":["R35GM127121"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jbc.2026.113341","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:26:50Z","timestamp":1784244410000},"page":"113341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK\u2013p65 NF-\u03baB signaling and inflammatory cytokine production to suppress triple-negative breast cancer progression"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3475-5244","authenticated-orcid":false,"given":"Julio M.","family":"Pimentel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oye","family":"Bosompra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4405-6228","authenticated-orcid":false,"given":"JoAnn","family":"Trejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113341_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2026.113341_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10549-010-0736-z","article-title":"Adjuvant therapy of triple negative breast cancer","volume":"120","author":"Perez","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jbc.2026.113341_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/GCO.0b013e3282f40de9","article-title":"Triple negative breast cancer: current understanding of biology and treatment options","volume":"20","author":"Kang","year":"2008","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.jbc.2026.113341_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/PPO.0b013e3181d24ff7","article-title":"Triple-negative breast cancer: role of specific chemotherapy agents","volume":"16","author":"Isakoff","year":"2010","journal-title":"Cancer J."},{"key":"10.1016\/j.jbc.2026.113341_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00002512-200219060-00004","article-title":"Efficacy and economics of hormonal therapies for advanced breast cancer","volume":"19","author":"Simon","year":"2002","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jbc.2026.113341_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1623137","article-title":"Inflammation-associated drug resistance and tumor growth in TNBC","volume":"16","author":"Hassan","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.jbc.2026.113341_bib7","first-page":"4678","article-title":"The role of the immune response and inflammatory pathways in TNF-related apoptosis-inducing ligand (TRAIL) resistance in triple-negative breast cancer cells","volume":"13","author":"Pimentel","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113341_bib8","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1158\/0008-5472.CAN-12-4524-T","article-title":"Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8","volume":"73","author":"Hartman","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2026.113341_bib9","doi-asserted-by":"crossref","first-page":"61969","DOI":"10.18632\/oncotarget.18755","article-title":"Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors","volume":"8","author":"Limoge","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2026.113341_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/1750-2187-9-6","article-title":"Breast cancer cell invasion mediated by G\u03b112 signaling involves expression of interleukins-6 and \u22128, and matrix metalloproteinase-2","author":"Chia","year":"2014","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.jbc.2026.113341_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13058-024-01953-z","article-title":"GRK6 palmitoylation dictates triple-negative breast cancer metastasis via recruiting the \u03b2-Arrestin 2\/MAPKs\/NF-\u03baB signaling axis","volume":"26","author":"Wang","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jbc.2026.113341_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-020-0167-1","article-title":"Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2026.113341_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1083\/jcb.201504007","article-title":"Ubiquitin plays an atypical role in GPCR-induced p38 MAP kinase activation on endosomes","volume":"210","author":"Grimsey","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113341_bib14","doi-asserted-by":"crossref","first-page":"C1605","DOI":"10.1152\/ajpcell.00161.2024","article-title":"Ubiquitin-driven G protein-coupled receptor inflammatory signaling at the endosome","volume":"326","author":"Cheng","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jbc.2026.113341_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s12935-021-02354-4","article-title":"PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-\u03baB signaling pathways","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2026.113341_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","article-title":"CXCR2 chemokine receptor; a master regulator in cancer and physiology","volume":"30","author":"Lazennec","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2026.113341_bib17","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.254888","article-title":"\u03b1-Arrestin ARRDC3 tumor suppressor function is linked to GPCR-induced TAZ activation and breast cancer metastasis","volume":"134","author":"Arakaki","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jbc.2026.113341_bib18","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1074\/jbc.RA117.001516","article-title":"The \u03b1-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein-coupled receptor lysosomal sorting and signaling","volume":"293","author":"Arakaki","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib19","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1038\/onc.2008.84","article-title":"Persistent transactivation of EGFR and ErbB2\/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion","volume":"27","author":"Arora","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113341_bib20","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1074\/jbc.RA119.007495","article-title":"G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2- and TAB1-TAB3-dependent pathway in endothelial cells","volume":"294","author":"Grimsey","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105370","article-title":"An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses","volume":"299","author":"Cheng","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/cdd.2009.43","article-title":"CYLD: a tumor suppressor deubiquitinase regulating NF-\u03baB activation and diverse biological processes","volume":"17","author":"Sun","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2026.113341_bib23","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/MCB.24.5.1990-1999.2004","article-title":"Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion","volume":"24","author":"Booden","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113341_bib24","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/j.celrep.2018.08.061","article-title":"A tyrosine switch on NEDD4-2 E3 ligase transmits GPCR inflammatory signaling","volume":"24","author":"Grimsey","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2026.113341_bib25","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1074\/jbc.272.19.12422","article-title":"Activation of transcription factor NF-\u03baB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways","volume":"272","author":"Wesselborg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib26","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1074\/jbc.M109.083808","article-title":"Differential regulation of mitogen- and stress-activated protein kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV radiation","volume":"285","author":"Jacks","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","article-title":"Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)","volume":"22","author":"Vermeulen","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2026.113341_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-kappaB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jbc.2026.113341_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071924","article-title":"Cylindromatosis Lysine 63 Deubiquitinase (CYLD) regulates NF-kB signaling pathway and modulates fibroblast and endothelial cells recruitment in nasopharyngeal carcinoma","volume":"12","author":"Deng","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2026.113341_bib30","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1038\/s41388-022-02329-3","article-title":"Role of p38 MAP kinase in cancer stem cells and metastasis","volume":"41","author":"Kudaravalli","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2026.113341_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2006.03.041","article-title":"Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling","volume":"125","author":"Massoumi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.113341_bib32","article-title":"IL-6: the link between inflammation, immunity and breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2026.113341_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061913","article-title":"The p38 pathway: from biology to cancer therapy","volume":"21","author":"Martinez-Limon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.113341_bib34","doi-asserted-by":"crossref","first-page":"15998","DOI":"10.1074\/jbc.M110.205724","article-title":"Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms","volume":"286","author":"Dauletbaev","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12929-022-00877-0","article-title":"Thrombin induces IL-8\/CXCL8 expression by DCLK1-dependent RhoA and YAP activation in human lung epithelial cells","volume":"29","author":"Yuliani","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jbc.2026.113341_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1081\/IMM-120034231","article-title":"p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblasts","volume":"33","author":"Patil","year":"2004","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.jbc.2026.113341_bib37","first-page":"1357","article-title":"p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells","volume":"13","author":"Hashimoto","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jbc.2026.113341_bib38","first-page":"6137","article-title":"NF-kappa B subunit-specific regulation of the interleukin-8 promoter","volume":"13","author":"Kunsch","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.113341_bib39","doi-asserted-by":"crossref","first-page":"18453","DOI":"10.1074\/jbc.M116.729285","article-title":"Protease-activated Receptor-4 signaling and trafficking is regulated by the clathrin adaptor protein Complex-2 independent of \u03b2-Arrestins","volume":"291","author":"Smith","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib40","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.bbamcr.2011.06.009","article-title":"Thrombin activation of PI3K\/PDK1\/Akt signaling promotes cyclin D1 upregulation and RPE cell proliferation","volume":"1813","author":"Parrales","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.113341_bib41","doi-asserted-by":"crossref","first-page":"20638","DOI":"10.1074\/jbc.M109.004762","article-title":"Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of rho- and Ca2+-dependent signaling pathways","volume":"284","author":"Seminario-Vidal","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113341_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115267","article-title":"The role of IL-8 in cancer development and its impact on immunotherapy resistance","volume":"218","author":"Meier","year":"2025","journal-title":"Eur. J. Cancer"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826022131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826022131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:01:26Z","timestamp":1790107286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826022131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0021925826022131"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113341","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK\u2013p65 NF-\u03baB signaling and inflammatory cytokine production to suppress triple-negative breast cancer progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113341"}}